IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Nanomedicine-enabled neuroprotection: therapeutic role of berberine in neurodegenerative diseases
- Pal B. , et al.
2. Berberine's paradox in Neurodegeneration: Therapeutic promise and safety challenges in Parkinson's disease
- Alshahrani S.M. , et al.
3. The Beneficial Effects of Berberine on Brain Functions in Age-Related Neurological Disorders: From Molecular Signaling to Treatment
- Wang X. , et al.
4. In vitro evaluation of antioxidant and neuroprotective effects of berberine loaded in nanostructured lipid carriers
- Bogdanova R. , et al.
5. Lead Phytomolecules for Treating Parkinson’s Disease
- Agrawal K.K. , et al.
6. Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action
- Remali J. , et al.
7. Neuroprotective effect and preparation methods of berberine
- Sunhe Y.X. , et al.
8. The therapeutic potential of berberine chloride against SARM1-dependent axon degeneration in acrylamide-induced neuropathy
- Wang S. , et al.
9. How neurons maintain their axons long-term: an integrated view of axon biology and pathology
- Smith G. , et al.
10. Can Berberine Serve as a New Therapy for Parkinson’s Disease?
- Dadgostar E. , et al.
11. The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine
- Chen P. , et al.
12. Berberine in the Treatment of Neurodegenerative Diseases and Nanotechnology Enabled Targeted Delivery
- Mohi-Ud-din R. , et al.
13. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases
- Plazas E. , et al.
14. Cell-Type-Specific High Throughput Toxicity Testing in Human Midbrain Organoids
- Renner H. , et al.
15. Potential of naturally derived alkaloids as multi-targeted therapeutic agents for neurodegenerative diseases
- Kong Y.R. , et al.
16. Paeonol protection against intrastriatal 6-Hydroxydopamine rat model of Parkinson's disease
- Ghalami J. , et al.
17. Ameliorating effects of berberine on MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia
- Ghotbi Ravandi S. , et al.
18. Trehalose neuroprotective effects on the substantia nigra dopaminergic cells by activating autophagy and non-canonical Nrf2 pathways
- Darabi S. , et al.
19. Berberine alleviates amyloid β-induced mitochondrial dysfunction and synaptic loss
- Zhao C. , et al.
20. Berberine alleviates symptoms of anxiety by enhancing dopamine expression in rats with post-traumatic stress disorder
- Lee B. , et al.
21. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling
- Baluchnejadmojarad T. , et al.
22. Acetyl-L-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat
- Afshin-Majd S. , et al.
23. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling
- Baluchnejadmojarad T. , et al.